Vitrolife AB (publ)

SSE:VITR.ST

187.4 (SEK) • At close February 20, 2024
Bedrijfsnaam Vitrolife AB (publ)
Symbool VITR.ST
Munteenheid SEK
Prijs 187.4
Beurswaarde 25,372,916,557
Dividendpercentage 0.55%
52-weken bereik 123.9 - 244.2
Industrie Medical Devices
Sector Healthcare
CEO Ms. Bronwyn Brophy
Website https://www.vitrolife.com

An error occurred while fetching data.

Over Vitrolife AB (publ)

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes;

Vergelijkbare Aandelen

AddLife AB (publ) logo

AddLife AB (publ)

ALIF-B.ST

102 SEK

Medicover AB (publ) logo

Medicover AB (publ)

MCOV-B.ST

145.3 SEK

Elekta AB (publ) logo

Elekta AB (publ)

EKTA-B.ST

77.06 SEK

Vimian Group AB (publ) logo

Vimian Group AB (publ)

VIMIAN.ST

29.12 SEK

Arjo AB (publ) logo

Arjo AB (publ)

ARJO-B.ST

50.05 SEK

Swedencare AB (publ) logo

Swedencare AB (publ)

SECARE.ST

60.34 SEK

Biotage AB (publ) logo

Biotage AB (publ)

BIOT.ST

184.3 SEK

Camurus AB (publ) logo

Camurus AB (publ)

CAMX.ST

440 SEK

Synsam AB (publ) logo

Synsam AB (publ)

SYNSAM.ST

45.15 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)